Jia An Chong1, Yan Ling Quah1, Grace Meijuan Yang2, Sumytra Menon3, Lalit Kumar Radha Krishna2. 1. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore. 2. Department of Palliative Medicine, National Cancer Centre Singapore, Singapore, Republic of Singapore. 3. Lien Centre for Palliative Care, Duke-NUS Graduate Medical School Singapore, Singapore, Republic of Singapore.
Abstract
BACKGROUND: The practice of patient autonomy within the prevailing bioethical framework in the West appears increasingly at odds with the prominent influence of the family in medical decision making in the Asian culture. The actual extent of involvement of patient versus the family in the decision making process for cancer management in clinical practice is largely unknown in Asia. AIMS: (1) To describe patient and family involvement in healthcare decision making in actual practice, and to determine whether those practices are consistent with Singapore law; and (2) to act as a pilot for a larger prospective study examining the preferences of cancer patients on the decision making process, and the reasons for excluding patients from that process. METHODS: A retrospective review of patients who died in an oncology ward in Singapore General Hospital from February to April 2011. Patient and family involvement in discussions on (1) disclosure of diagnosis, (2) initial treatment decisions and (3) initiation of a 'maximum ward management' order was evaluated by reviewing case notes completed by healthcare professionals. RESULTS: Data were collected for 55 patients. Involvement of patients and families at first disclosure of diagnosis was noted in 61% and 64% of cases, respectively. In 12% of cases, the family requested withholding of the diagnosis from the patient. 86% of patients were involved in the initial treatment decisions, and their family was involved in 65% of cases. Only 9% of the 32 alert patients were consulted in end of life decisions. Factors associated with lower patient involvement were advanced age and inability to speak English. CONCLUSIONS: While most cancer patients are involved in the healthcare decision making process during the early phase, familial involvement gains prominence as the disease progresses. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: The practice of patient autonomy within the prevailing bioethical framework in the West appears increasingly at odds with the prominent influence of the family in medical decision making in the Asian culture. The actual extent of involvement of patient versus the family in the decision making process for cancer management in clinical practice is largely unknown in Asia. AIMS: (1) To describe patient and family involvement in healthcare decision making in actual practice, and to determine whether those practices are consistent with Singapore law; and (2) to act as a pilot for a larger prospective study examining the preferences of cancerpatients on the decision making process, and the reasons for excluding patients from that process. METHODS: A retrospective review of patients who died in an oncology ward in Singapore General Hospital from February to April 2011. Patient and family involvement in discussions on (1) disclosure of diagnosis, (2) initial treatment decisions and (3) initiation of a 'maximum ward management' order was evaluated by reviewing case notes completed by healthcare professionals. RESULTS: Data were collected for 55 patients. Involvement of patients and families at first disclosure of diagnosis was noted in 61% and 64% of cases, respectively. In 12% of cases, the family requested withholding of the diagnosis from the patient. 86% of patients were involved in the initial treatment decisions, and their family was involved in 65% of cases. Only 9% of the 32 alert patients were consulted in end of life decisions. Factors associated with lower patient involvement were advanced age and inability to speak English. CONCLUSIONS: While most cancerpatients are involved in the healthcare decision making process during the early phase, familial involvement gains prominence as the disease progresses. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Decision Making; Family; Neoplasms; Personal Autonomy; Terminal care
Authors: Keith Zi Yuan Chua; Elaine Li Ying Quah; Yun Xue Lim; Chloe Keyi Goh; Jieyu Lim; Darius Wei Jun Wan; Simone Meiqi Ong; Chi Sum Chong; Kennan Zhi Guang Yeo; Laura Shih Hui Goh; Ray Meng See; Alexia Sze Inn Lee; Yun Ting Ong; Min Chiam; Eng Koon Ong; Jamie Xuelian Zhou; Crystal Lim; Simon Yew Kuang Ong; Lalit Krishna Journal: BMC Palliat Care Date: 2022-07-04 Impact factor: 3.113
Authors: Rui Song Ryan Ong; Ruth Si Man Wong; Ryan Choon Hoe Chee; Chrystie Wan Ning Quek; Neha Burla; Caitlin Yuen Ling Loh; Yu An Wong; Amanda Kay-Lyn Chok; Andrea York Tiang Teo; Aiswarya Panda; Sarah Wye Kit Chan; Grace Shen Shen; Ning Teoh; Annelissa Mien Chew Chin; Lalit Kumar Radha Krishna Journal: BMC Med Educ Date: 2022-06-17 Impact factor: 3.263
Authors: Grace Meijuan Yang; J Nicholas Dionne-Odom; Yi Han Foo; Ariel Hui Mei Chung; Nur Haidah Ahmad Kamal; Laurence Tan; Chou Chuen Yu; Le Mai Khanh; Audrey Rui Xuan Koh; Irene Teo; Sungwon Yoon; Marie Bakitas Journal: BMC Palliat Care Date: 2021-06-22 Impact factor: 3.234